150,686 Shares in Fresenius Medical Care AG (NYSE:FMS) Purchased by Broyhill Asset Management

Broyhill Asset Management purchased a new position in shares of Fresenius Medical Care AG (NYSE:FMS) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 150,686 shares of the company’s stock, valued at approximately $3,412,000. Fresenius Medical Care makes up about 3.0% of Broyhill Asset Management’s holdings, making the stock its 10th biggest position.

A number of other institutional investors also recently made changes to their positions in the stock. Smartleaf Asset Management LLC lifted its position in Fresenius Medical Care by 192.8% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,224 shares of the company’s stock worth $28,000 after purchasing an additional 806 shares during the period. Wilmington Savings Fund Society FSB acquired a new stake in shares of Fresenius Medical Care in the third quarter valued at $38,000. Russell Investments Group Ltd. boosted its stake in Fresenius Medical Care by 234.1% during the fourth quarter. Russell Investments Group Ltd. now owns 3,151 shares of the company’s stock valued at $71,000 after buying an additional 2,208 shares in the last quarter. Jones Financial Companies Lllp grew its holdings in Fresenius Medical Care by 80.5% during the fourth quarter. Jones Financial Companies Lllp now owns 4,510 shares of the company’s stock worth $102,000 after acquiring an additional 2,012 shares during the period. Finally, Venturi Wealth Management LLC raised its position in Fresenius Medical Care by 8.4% in the fourth quarter. Venturi Wealth Management LLC now owns 5,700 shares of the company’s stock worth $129,000 after acquiring an additional 441 shares in the last quarter. 8.37% of the stock is owned by institutional investors and hedge funds.

Fresenius Medical Care Trading Up 0.6 %

Shares of FMS opened at $23.96 on Monday. The business’s 50-day moving average price is $23.94 and its 200 day moving average price is $22.79. The company has a current ratio of 1.37, a quick ratio of 1.02 and a debt-to-equity ratio of 0.42. The stock has a market capitalization of $14.06 billion, a P/E ratio of 19.80, a P/E/G ratio of 0.76 and a beta of 0.93. Fresenius Medical Care AG has a 1-year low of $17.93 and a 1-year high of $25.96.

Analyst Ratings Changes

Several equities analysts have recently weighed in on FMS shares. StockNews.com upgraded shares of Fresenius Medical Care from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, February 5th. Truist Financial lifted their price target on shares of Fresenius Medical Care from $23.00 to $25.00 and gave the stock a “hold” rating in a research report on Monday, January 6th.

Fresenius Medical Care Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.